speb/financial-data huggingface dataset:
9988.HK — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category:  (confidence: Medium)
Market cap (USD): 204055369997.85052
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
9988.HK — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 314464707505.38043
Net income (USD): 1729889807.1625345
P/E ratio: 45.4457714883562
P/B ratio: 2.0943043855267853
Pays dividend: no
Net asset value (USD): 99250275482.09367
Net cash (USD): -39397796143.25069
Net cash to market cap %: -12.528527113834102
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 2.7609178040034927 (Grey Zone)
Piotroski F-score: 4 (Weak)
9988.HK — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 267912302041.62042
Net income (USD): 6013389121.338912
P/E ratio: 34.599335051135675
P/B ratio: 1.7569723069281866
Pays dividend: no
Net asset value (USD): 102924546722.45467
Net cash (USD): -47050348675.03487
Net cash to market cap %: -17.56184703594744
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 2.3544748276326923 (Grey Zone)
Piotroski F-score: 7 (Neutral)
9988.HK — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 435750139407.0951
Net income (USD): 2952106741.573034
P/E ratio: 40.741881859044796
P/B ratio: 2.790594397818389
Pays dividend: no
Net asset value (USD): 106392556179.77528
Net cash (USD): -55972331460.67415
Net cash to market cap %: -12.845051876938719
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 3.1764331290680485 (Safe Zone)
Piotroski F-score: 4 (Weak)
9988.HK — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 351557691657.39844
Net income (USD): 2340428571.428571
P/E ratio: 26.968602432068963
P/B ratio: 2.2251935402682532
Pays dividend: no
Net asset value (USD): 110799285714.28572
Net cash (USD): -62037285714.285706
Net cash to market cap %: -17.646402620808693
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 2.7050883877863288 (Grey Zone)
Piotroski F-score: 7 (Neutral)
9988.HK — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 305245670955.7164
Net income (USD): 3696237337.1924744
EPS growth %: 113.66894711376194
Revenue growth %: 8.142597030312436
Smoothed growth %: 113.66894711376194
P/E ratio: 2.3802181783231346
P/B ratio: 1.7837196731199652
PEG ratio: 0.020939915770847858
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 113684659913.16931
Net cash (USD): -67497250361.7945
Net cash to market cap %: -22.112434928384843
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 2.345440346138644 (Grey Zone)
Piotroski F-score: 4 (Weak)
9989.HK — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 101822068.94329898
Net income (USD): -18270156.91780822
P/B ratio: 0.060915731829614975
Pays dividend: no
Net asset value (USD): 1285770494.9561644
Net cash (USD): -353965107.79315066
Net cash to market cap %: -347.63103074468165
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9135798711050108 (Distress Zone)
Piotroski F-score: 0 (Weak)
9989.HK — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 112876228.14910026
Net income (USD): 21568896.493112948
P/E ratio: 1.3083217792938802
P/B ratio: 0.06640835104945218
Pays dividend: no
Net asset value (USD): 1314255482.6019285
Net cash (USD): -289788500.12809926
Net cash to market cap %: -256.73120450597656
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9459325739668027 (Distress Zone)
Piotroski F-score: 4 (Weak)
9989.HK — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 143832456.68789807
Net income (USD): 36995858.37099024
P/E ratio: 0.9719497196521477
P/B ratio: 0.0844481699262203
Pays dividend: no
Net asset value (USD): 1315909242.2914922
Net cash (USD): -273435014.08228725
Net cash to market cap %: -190.10661458394864
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9551459360534253 (Distress Zone)
Piotroski F-score: 6 (Neutral)
9989.HK — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 149652944.0874036
P/E ratio: 3.713970400867692
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
9989.HK — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: High)
Market cap (USD): 141166009.6401028
Net income (USD): -29155704.11142857
Revenue growth %: 10.544661345508777
Smoothed growth %: 10.544661345508777
P/E ratio: 4.800087252978216
P/B ratio: 0.08180036715056084
Pays dividend: no
Net asset value (USD): 1342731940.982857
Net cash (USD): -245925766.7057143
Net cash to market cap %: -174.21032678666228
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.9416769924257213 (Distress Zone)
Piotroski F-score: 1 (Weak)
9989.HK — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: High)
Market cap (USD): 934313085.9623734
Net income (USD): 27144952.4211288
EPS growth %: 25.852300463291257
Revenue growth %: 0.28703427820153166
Smoothed growth %: 25.852300463291257
P/E ratio: 1.9897959183673468
P/B ratio: 0.07423960899188715
PEG ratio: 0.07696784745298546
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 1389491367.4196818
Net cash (USD): -185126642.4529668
Net cash to market cap %: -19.81419774959913
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.6350933142779167 (Distress Zone)
Piotroski F-score: 5 (Neutral)
9991.HK — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category:  (confidence: Low)
Market cap (USD): 191604809.2972973
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
9991.HK — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category:  (confidence: Low)
Market cap (USD): 149910112.33505154
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
9991.HK — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Turnaround (confidence: High)
Market cap (USD): 151181523.11053982
Net income (USD): -8688705.23415978
P/B ratio: 0.19255981611403775
Pays dividend: no
Net asset value (USD): 426297796.1432507
Net cash (USD): -247786639.11845732
Net cash to market cap %: -163.90008118735676
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.6513748181243342 (Distress Zone)
Piotroski F-score: 1 (Weak)
9991.HK — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Turnaround (confidence: High)
Market cap (USD): 142854865.34522292
Net income (USD): -2852719.6652719667
P/B ratio: 0.1807556111312728
Pays dividend: no
Net asset value (USD): 425683263.5983264
Net cash (USD): -194019246.86192465
Net cash to market cap %: -135.81563805548936
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.709500675381717 (Distress Zone)
Piotroski F-score: 5 (Neutral)
9991.HK — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Turnaround (confidence: High)
Market cap (USD): 221594835.24421594
Net income (USD): -13302528.08988764
P/B ratio: 0.28574012140927907
Pays dividend: no
Net asset value (USD): 427512921.3483146
Net cash (USD): -243636938.20224714
Net cash to market cap %: -109.94702919575674
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.6924513046569296 (Distress Zone)
Piotroski F-score: 3 (Weak)
9991.HK — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Turnaround (confidence: High)
Market cap (USD): 140826624.2673522
Net income (USD): -1734857.142857143
P/B ratio: 0.17950830467220893
Pays dividend: no
Net asset value (USD): 429850857.14285713
Net cash (USD): -220736714.28571427
Net cash to market cap %: -156.7435954913304
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.7903393110561787 (Distress Zone)
Piotroski F-score: 5 (Neutral)
9991.HK — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Cyclical | Industry: Internet Retail
Lynch category: Turnaround (confidence: High)
Market cap (USD): 166850334.00868306
Net income (USD): -255282.1997105644
Revenue growth %: 21.183445101328108
Smoothed growth %: 21.183445101328108
P/B ratio: 0.1552714298335171
Pays dividend: no
Net asset value (USD): 434211722.1418234
Net cash (USD): -219306078.1476122
Net cash to market cap %: -131.43880079748556
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.6493283880805281 (Distress Zone)
Piotroski F-score: 3 (Weak)
9994.T — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 218470665.3818462
P/B ratio: 0.8918470266245425
Pays dividend: no
Net asset value (USD): 223791847.59770277
Net cash (USD): -97254517.43941727
Net cash to market cap %: -44.51605311378277
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
9994.T — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 199989380.1239139
P/B ratio: 0.8015861944906104
Pays dividend: no
Net asset value (USD): 226420264.67049858
Net cash (USD): -113788263.60112284
Net cash to market cap %: -56.897153004134196
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
9994.T — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category:  (confidence: Low)
Market cap (USD): 180830014.45765293
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
9994.T — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 171816713.50309557
P/B ratio: 0.6687611615736812
Pays dividend: no
Net asset value (USD): 233162853.2974428
Net cash (USD): -79057873.48586811
Net cash to market cap %: -46.01291217483551
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
9994.T — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 139926409.6096096
P/E ratio: 0.07181718634888476
P/B ratio: 0.6027269483473162
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): 223942692.6926927
Net cash (USD): -80987237.23723723
Net cash to market cap %: -57.87845015332641
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
AA4.L — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Industrials | Industry: Rental & Leasing Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 55627309.9843421
Net income (USD): 32562182.89473684
P/E ratio: 1.7083409353779342
P/B ratio: 0.134740594977839
Pays dividend: no
Net asset value (USD): 412847442.1052632
Net cash (USD): -1286113953.9473684
Net cash to market cap %: -2312.018960308133
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 3 (Weak)
AA4.L — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Industrials | Industry: Rental & Leasing Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 87342954.42617284
Net income (USD): 72606467.90123457
EPS growth %: 122.97788860147409
Revenue growth %: 3.604766075619201
Smoothed growth %: 122.97788860147409
P/E ratio: 1.2029638261013342
P/B ratio: 0.2072732403455185
PEG ratio: 0.009781952184914278
Pays dividend: no
Net asset value (USD): 421390403.7037037
Net cash (USD): -1150867422.222222
Net cash to market cap %: -1317.6419664106963
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 7 (Neutral)
AA4.L — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Industrials | Industry: Rental & Leasing Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 100666007.47987342
Net income (USD): 33100001.265822783
EPS growth %: -54.41177318961694
Revenue growth %: -19.89830008034024
EPS 2-year CAGR %: 0.8224506707922075
Smoothed growth %: 0.8224506707922075
P/E ratio: 3.0412689918479106
P/B ratio: 0.2347028651245242
PEG ratio: 3.697813254767578
Pays dividend: no
Net asset value (USD): 428908302.53164554
Net cash (USD): -990645739.2405062
Net cash to market cap %: -984.091615472651
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 5 (Neutral)
AA4.L — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Industrials | Industry: Rental & Leasing Services
Lynch category: Asset Play (confidence: High)
Market cap (USD): 181832234.10714287
Net income (USD): 17796562.337662335
EPS growth %: -46.23395269764514
Revenue growth %: -7.437906140916222
EPS 2-year CAGR %: -50.49142741789522
Smoothed growth %: -46.23395269764514
P/E ratio: 10.217267282138906
P/B ratio: 0.476773629950765
Pays dividend: no
Net asset value (USD): 381380644.15584415
Net cash (USD): -877121840.2597404
Net cash to market cap %: -482.3797301763915
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 6 (Neutral)
AAA.PA — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 236532911.45833337
P/B ratio: 4.1158527279318475
Pays dividend: no
Net asset value (USD): -184922916.6666667
Net cash (USD): -291103125.00000006
Net cash to market cap %: -123.0708755095502
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
AAA.PA — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 219057303.41176468
P/B ratio: 4.442398909672187
Pays dividend: no
Net asset value (USD): -209780000
Net cash (USD): -324838823.5294118
Net cash to market cap %: -148.28942859704992
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
AAA.PA — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Industrials | Industry: Consulting Services
Lynch category:  (confidence: Low)
Market cap (USD): 101514362.35294119
P/B ratio: 4.339649225358946
Pays dividend: no
Net asset value (USD): -209403529.4117647
Net cash (USD): -303278823.5294118
Net cash to market cap %: -298.7545963939406
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
AAL.AX — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Industrials | Industry: Conglomerates
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 2206896.551724138
Pays dividend: no
Net asset value (USD): 0
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
AAL.AX — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Industrials | Industry: Conglomerates
Lynch category: Fast Grower (confidence: Medium)
Net income (USD): 3245033.1125827814
EPS growth %: 47.040562913907266
Revenue growth %: 7.346169027674223
Smoothed growth %: 47.040562913907266
Pays dividend: no
Net asset value (USD): 0
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
AAL.AX — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Industrials | Industry: Conglomerates
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 44006980.693333335
Net income (USD): 2442936
EPS growth %: -24.717686530612244
Revenue growth %: 14.821698886255923
EPS 2-year CAGR %: 5.211946802632639
Smoothed growth %: 5.211946802632639
P/E ratio: 18.013971996537503
P/B ratio: 1.1633022787943899
PEG ratio: 3.456284701033087
Pays dividend: no
Net asset value (USD): 37669404
Net cash (USD): -23627805.333333336
Net cash to market cap %: -53.69103937847011
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.9963162081069128 (Grey Zone)
Piotroski F-score: 3 (Weak)
AAL.AX — Peter Lynch category analysis (annual, as of 2025-06-30)
Sector: Industrials | Industry: Conglomerates
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 45019926.79738562
Net income (USD): 7954541.176470588
EPS growth %: 225.61398155623345
Revenue growth %: -3.3017137885873966
EPS 2-year CAGR %: 56.566196318144655
Smoothed growth %: 56.566196318144655
P/E ratio: 7.625272331154684
P/B ratio: 1.5485680156897417
PEG ratio: 0.13480263527474864
Dividend yield: 0.14
Pays dividend: yes
Net asset value (USD): 42239907.18954248
Net cash (USD): -38407422.222222224
Net cash to market cap %: -85.31204947328482
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0383617201342994 (Grey Zone)
Piotroski F-score: 5 (Neutral)
AAPG — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
AAPG — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Net income (USD): -126856896.55172414
Pays dividend: no
Net asset value (USD): 43054597.70114943
Net cash (USD): -135914367.81609192
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
AAPG — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Net income (USD): -130188045.00703235
Revenue growth %: 3.619167925833714
Smoothed growth %: 3.619167925833714
Pays dividend: no
Net asset value (USD): -6993389.592123769
Net cash (USD): -191345288.326301
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
AAPG — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Net income (USD): -55538767.12328767
Revenue growth %: 330.2680521464215
Smoothed growth %: 330.2680521464215
Pays dividend: no
Net asset value (USD): 22397534.246575344
Net cash (USD): -151653424.65753424
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 6 (Neutral)
AAPG — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 1707137792
Net income (USD): -177538428.57142857
Revenue growth %: -38.946092606216
Smoothed growth %: -38.946092606216
P/B ratio: 12.849666945642818
Pays dividend: no
Net asset value (USD): 176261714.2857143
Net cash (USD): -23566428.571428537
Net cash to market cap %: -1.3804643469241724
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: -0.20883406311497327 (Distress Zone)
Piotroski F-score: 4 (Weak)
AARTIDRUGS.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 555174958.1939799
P/B ratio: 3.63747437957284
Pays dividend: no
Net asset value (USD): 152312470.1385571
Net cash (USD): -134042164.35738176
Net cash to market cap %: -24.14413013033398
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
AARTIDRUGS.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 360521293.03302604
Net income (USD): 7348608.83797054
P/E ratio: 12.264950447838471
P/B ratio: 2.252101621744756
Pays dividend: no
Net asset value (USD): 152654980.1262567
Net cash (USD): -140091664.71826044
Net cash to market cap %: -38.85808339909265
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.806590660397333 (Grey Zone)
Piotroski F-score: 3 (Weak)
AARTIDRUGS.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 486680774.63140655
Net income (USD): 6315235.197753335
P/E ratio: 19.26613813229572
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
AARTIDRUGS.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 497920552.4239008
Net income (USD): 5104847.801578354
P/E ratio: 26.529315774384347
P/B ratio: 3.0073439830041053
Pays dividend: no
Net asset value (USD): 164418263.8105975
Net cash (USD): -126171364.14881623
Net cash to market cap %: -25.339657809786736
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.896121531281667 (Grey Zone)
Piotroski F-score: 3 (Weak)
AARTIDRUGS.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 416291650.8855966
Net income (USD): 4517099.253648212
P/E ratio: 17.877496592648722
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
AARTIDRUGS.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 391253861.4667232
Net income (USD): 5856295.040271302
EPS growth %: -20.307432748201215
Revenue growth %: -3.514945447000659
Smoothed growth %: -20.307432748201215
P/E ratio: 0.15794016974456124
P/B ratio: 1.8754066301365437
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 162402501.0597711
Net cash (USD): -131597647.30818142
Net cash to market cap %: -33.63484945933857
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.329180469349575 (Grey Zone)
Piotroski F-score: 3 (Weak)
AARTIIND.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 4526501967.711328
Pays dividend: no
Net cash (USD): 12347355.927733088
Net cash to market cap %: 0.2727792015956222
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
AARTIIND.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2272409845.387333
Net income (USD): 66410475.03045067
P/E ratio: 34.21764178535664
P/B ratio: 3.7913519815131687
Pays dividend: no
Net asset value (USD): 586037758.8306943
Net cash (USD): -421595615.1035323
Net cash to market cap %: -18.552798297336686
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.561960625370947 (Safe Zone)
Piotroski F-score: 4 (Weak)
AARTIIND.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2884147168.6648273
Net income (USD): 49941239.956829354
EPS growth %: -24.799152642816978
Revenue growth %: -6.103549963095295
Smoothed growth %: -24.799152642816978
P/E ratio: 57.7508121776305
P/B ratio: 4.54606345338447
Pays dividend: no
Net asset value (USD): 612344405.8040532
Net cash (USD): -516093056.72142947
Net cash to market cap %: -17.894130449672822
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.249850498404625 (Safe Zone)
Piotroski F-score: 5 (Neutral)
AARTIIND.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1649646636.812347
Net income (USD): 38695347.2059855
EPS growth %: -22.51824896731664
Revenue growth %: 14.448523027413401
EPS 2-year CAGR %: -23.66721980448977
Smoothed growth %: -22.51824896731664
P/E ratio: 42.63165356886047
P/B ratio: 2.517488578734255
Pays dividend: no
Net asset value (USD): 628532850.1285948
Net cash (USD): -609504325.4617722
Net cash to market cap %: -36.947568761727815
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.7461290110933914 (Grey Zone)
Piotroski F-score: 7 (Neutral)
AARTIIND.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Basic Materials | Industry: Specialty Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1836697795.3370073
Net income (USD): 44404408.64773209
EPS growth %: 14.75387056577048
Revenue growth %: 3.3359826881603327
EPS 2-year CAGR %: -5.706146386873135
Smoothed growth %: 14.75387056577048
P/E ratio: 0.3642107638085211
P/B ratio: 2.419893739461309
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 604175498.092412
Net cash (USD): -707609156.4222127
Net cash to market cap %: -38.526161365178574
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 2.130194651945937 (Grey Zone)
Piotroski F-score: 5 (Neutral)
AARTIPHARM.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 683987041.4640468
P/B ratio: 3.084104683331693
Pays dividend: no
Net asset value (USD): 210820138.55709508
Net cash (USD): -97426588.62876254
Net cash to market cap %: -14.243923162670574
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
AARTIPHARM.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 789069933.0546155
Net income (USD): 10327425.765723638
P/E ratio: 19.101321833595524
P/B ratio: 3.3919707014104703
Pays dividend: no
Net asset value (USD): 220912590.60088846
Net cash (USD): -100646036.94178163
Net cash to market cap %: -12.755021161706766
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 5.6642638673481 (Safe Zone)
Piotroski F-score: 2 (Weak)
AARTIPHARM.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 940190286.7412827
Net income (USD): 5792335.595600281
P/E ratio: 40.57906656234787
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
AARTIPHARM.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 844334358.0236752
Net income (USD): 3148038.3314543404
P/E ratio: 43.82100558893288
P/B ratio: 3.6600651252591616
Pays dividend: no
Net asset value (USD): 217777869.22209695
Net cash (USD): -131238579.48139796
Net cash to market cap %: -15.54343705597706
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 4.052183387807522 (Safe Zone)
Piotroski F-score: 2 (Weak)
AARTIPHARM.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 758419409.5859418
Net income (USD): 5342051.910437786
P/E ratio: 30.817715678010458
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
AARTIPHARM.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: High)
Market cap (USD): 647520778.6350149
Net income (USD): 6477755.404832556
EPS growth %: -37.276185258750566
Revenue growth %: -6.3134518289159285
Smoothed growth %: -37.276185258750566
P/E ratio: 0.32410565291287735
P/B ratio: 2.515293860279378
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 212030256.46460363
Net cash (USD): -142802596.43916914
Net cash to market cap %: -22.05374733150641
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 3.1237842020729985 (Safe Zone)
Piotroski F-score: 2 (Weak)
AATG.L — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 3222083.1825
P/B ratio: 0.010256511801687091
Pays dividend: no
Net asset value (USD): 314150000
Net cash (USD): 56237500
Net cash to market cap %: 1745.3770376084942
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
AATG.L — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Lynch category: Asset Play (confidence: High)
Market cap (USD): 362156064.8648649
P/B ratio: 0.009363146748477665
Pays dividend: no
Net asset value (USD): 377931081.0810811
Net cash (USD): 80594594.5945946
Net cash to market cap %: 22.254106009426547
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
AAU.L — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1454493.7037837838
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
AAU.L — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 972583.1392771085
Net income (USD): 4855421.686746988
P/E ratio: 0.20030868625310172
P/B ratio: 0.029800797607796806
Pays dividend: no
Net asset value (USD): 32443373.493975904
Net cash (USD): 10314457.831325302
Net cash to market cap %: 1060.521966172653
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.670598963102638 (Grey Zone)
Piotroski F-score: 2 (Weak)
AAU.L — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 681218.5701265823
Net income (USD): -275949.36708860757
EPS growth %: -105.68332443383484
Smoothed growth %: -105.68332443383484
P/B ratio: 0.025014533345728368
Pays dividend: no
Net asset value (USD): 26913924.05063291
Net cash (USD): 4668354.4303797465
Net cash to market cap %: 685.2946521279191
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.8030191001440947 (Grey Zone)
Piotroski F-score: 1 (Weak)
AAU.L — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 672703.338
Net income (USD): 3365000
EPS 2-year CAGR %: -16.75099386579738
P/E ratio: 0.19991183893016343
P/B ratio: 0.012398061842559956
Pays dividend: no
Net asset value (USD): 53967500
Net cash (USD): -1591250
Net cash to market cap %: -236.545578134176
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.0782821027317409 (Distress Zone)
Piotroski F-score: 3 (Weak)
AAU.L — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 59088805.40540541
Net income (USD): -16702702.702702703
EPS growth %: -596.3656078069154
P/B ratio: 0.011861118540068763
Pays dividend: no
Net asset value (USD): 61022972.972972974
Net cash (USD): 5840540.540540541
Net cash to market cap %: 9.884343574842775
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 24.227845919394586 (Safe Zone)
Piotroski F-score: 4 (Weak)
ABBV — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 329047494983.04004
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ABBV — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category:  (confidence: Medium)
Market cap (USD): 298446643323.32
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ABBV — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 355213696662.05005
Net income (USD): 1289000000
P/E ratio: 68.89326932933476
P/B ratio: 242.96422480304378
Pays dividend: no
Net asset value (USD): -92354000000
Net cash (USD): -129527000000
Net cash to market cap %: -36.46452859705797
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.6018088839045141 (Distress Zone)
Piotroski F-score: 4 (Weak)
ABBV — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 317598677502.95996
Net income (USD): 941000000
P/E ratio: 142.42093161567712
Pays dividend: no
Net asset value (USD): -92852000000
Net cash (USD): -130853000000
Net cash to market cap %: -41.200738311884336
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.4283608903360017 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ABBV — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 399595532325.57
Net income (USD): 188000000
P/E ratio: 165.25869823224565
Pays dividend: no
Net asset value (USD): -92583000000
Net cash (USD): -130826000000
Net cash to market cap %: -32.73960528002341
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.741216220126765 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ABBV — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 397175026160.80005
Net income (USD): 1816000000
P/E ratio: 93.80609970732169
Pays dividend: no
Net asset value (USD): -91551000000
Net cash (USD): -131931000000
Net cash to market cap %: -33.217345328904564
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.7148615789201365 (Distress Zone)
Piotroski F-score: 8 (Strong)
ABBV — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - General
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 458235346944
Net income (USD): 697000000
EPS growth %: -45.927075252133434
Revenue growth %: 12.433485722850932
Smoothed growth %: -45.927075252133434
P/E ratio: 105.21951219512195
Dividend yield: 0.03
Pays dividend: yes
Net asset value (USD): -93099000000
Net cash (USD): -133684000000
Net cash to market cap %: -29.173655173383484
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.8873497280656295 (Grey Zone)
Piotroski F-score: 5 (Neutral)
ABCB — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Medium)
Market cap (USD): 4104238860.9199996
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ABCB — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Medium)
Market cap (USD): 4129068298.11
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ABCB — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 3812325207.4700003
Net income (USD): 87935000
P/E ratio: 10.83847503118781
P/B ratio: 0.9969985913156593
Pays dividend: no
Net asset value (USD): 2741498000
Net cash (USD): -21398738000
Net cash to market cap %: -561.3041080039704
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 4 (Weak)
ABCB — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 4297505831.4800005
Net income (USD): 109834000
P/E ratio: 21.729926487366576
P/B ratio: 1.0969522843582349
Pays dividend: no
Net asset value (USD): 2839450000
Net cash (USD): -21592205000
Net cash to market cap %: -502.435734742539
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
ABCB — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 4882675270.12
Net income (USD): 106029000
P/E ratio: 16.072111304616886
P/B ratio: 1.2155934111401372
Pays dividend: no
Net asset value (USD): 2942352000
Net cash (USD): -22039964000
Net cash to market cap %: -451.39114892353535
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
ABCB — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 4959847845.17
Net income (USD): 108356000
P/E ratio: 12.033967510129708
P/B ratio: 1.2168336049629687
Pays dividend: no
Net asset value (USD): 3005558000
Net cash (USD): -22350931000
Net cash to market cap %: -450.63743279475375
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 4 (Weak)
ABCB — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 5894150144
Net income (USD): 110492000
EPS growth %: 25.651901973048275
Revenue growth %: 10.528574622936157
Smoothed growth %: 25.651901973048275
P/E ratio: 12.235849056603772
P/B ratio: 1.2828367621732493
PEG ratio: 0.4769957825918574
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 3015051000
Net cash (USD): -22698509000
Net cash to market cap %: -385.102320868194
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 4 (Weak)
ABCB — Peter Lynch category analysis (quarterly, as of 2026-06-30)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Medium)
Market cap (USD): 5887261184
P/E ratio: 14.19182389937107
Dividend yield: 0.01
Pays dividend: yes
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ABEO.PA — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Turnaround (confidence: Low)
Market cap (USD): 140907756.03333333
Net income (USD): 7998888.888888889
P/E ratio: 17.615916159188775
P/B ratio: 1.1981046446791623
Pays dividend: no
Net asset value (USD): -28538888.888888888
Net cash (USD): -192394444.44444442
Net cash to market cap %: -136.5392863107772
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.240467710955518 (Distress Zone)
Piotroski F-score: 3 (Weak)
ABEO.PA — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 146926278.41304347
Net income (USD): 7313043.478260869
EPS growth %: -8.574258502086648
Revenue growth %: 13.538811344600443
Smoothed growth %: -8.574258502086648
P/E ratio: 20.090989319262782
P/B ratio: 1.2152492685426595
Pays dividend: no
Net asset value (USD): -24182608.695652172
Net cash (USD): -196754347.82608694
Net cash to market cap %: -133.91365380736408
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.3924151457796639 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ABEO.PA — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 87220618.1521739
Net income (USD): 1826881.7204301073
EPS growth %: -75.01885875749555
Revenue growth %: 3.11812118265898
EPS 2-year CAGR %: -52.209631079473006
Smoothed growth %: -75.01885875749555
P/E ratio: 47.74289280842951
P/B ratio: 0.7430375010902723
Pays dividend: no
Net asset value (USD): -25602150.537634406
Net cash (USD): -197153763.4408602
Net cash to market cap %: -226.04031892652472
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.20212003147244 (Distress Zone)
Piotroski F-score: 7 (Neutral)
ABEO.PA — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Consumer Cyclical | Industry: Leisure
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 80386837.76086955
Net income (USD): 7430434.782608695
EPS growth %: 306.7277426619239
Revenue growth %: 1.214744694966015
EPS 2-year CAGR %: 0.7994205671963295
Smoothed growth %: 0.7994205671963295
P/E ratio: 10.818591389701579
P/B ratio: 0.6525308658249291
PEG ratio: 13.533041097058295
Pays dividend: no
Net asset value (USD): -21770652.173913043
Net cash (USD): -193530434.7826087
Net cash to market cap %: -240.74890886778334
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.2750495463998908 (Distress Zone)
Piotroski F-score: 9 (Strong)
ABEV — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category:  (confidence: Medium)
Market cap (USD): 34614261003.840004
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ABEV — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category:  (confidence: Medium)
Market cap (USD): 27660503212.89
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ABEV — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 35232372807.479996
Net income (USD): 660529340.2777778
P/E ratio: 13.334900760299096
P/B ratio: 2.125546657579187
Pays dividend: no
Net asset value (USD): 6989665104.166667
Net cash (USD): -5470976388.888888
Net cash to market cap %: -15.52826549260223
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.7669210039954364 (Grey Zone)
Piotroski F-score: 3 (Weak)
ABEV — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 36777652316.58
Net income (USD): 509227372.2627737
P/E ratio: 31.44042852868437
P/B ratio: 2.162208619903542
Pays dividend: no
Net asset value (USD): 7195862591.240875
Net cash (USD): -5733943065.69343
Net cash to market cap %: -15.590834935128441
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.852801945326632 (Grey Zone)
Piotroski F-score: 4 (Weak)
ABEV — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 34305205102.020004
Net income (USD): 914233082.7067668
P/E ratio: 16.461311461435837
P/B ratio: 1.9681528800767816
Pays dividend: no
Net asset value (USD): 7654046240.601503
Net cash (USD): -5298056766.917294
Net cash to market cap %: -15.443885996779324
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.7436305347186063 (Grey Zone)
Piotroski F-score: 9 (Strong)
ABEV — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Consumer Defensive | Industry: Beverages - Brewers
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 38013875923.86
Net income (USD): 826544708.029197
P/E ratio: 13.060788621837716
P/B ratio: 2.3465672697967537
Pays dividend: no
Net asset value (USD): 6447627737.226276
Net cash (USD): -6567974452.554745
Net cash to market cap %: -17.277834193256396
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.6286796358468942 (Grey Zone)
Piotroski F-score: 6 (Neutral)